安德罗格拉福利德及其衍生物在心血管疾病中的作用:综合性综述
Shenjie Zhang1, Xiaokai Xie1, Juan Zhao2
1Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Planta medica
|March 7, 2025
概括
安德罗格拉福利德是一种天然化合物,由于其抗炎和抗氧化作用,在治疗心血管疾病方面表现有前途. 这篇评论探讨了它对心脏健康和血管功能的保护机制.
科学领域:
- 药理学和自然产品的研究.
- 心血管医学 心血管医学
- 植物化学 植物化学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 安德罗格拉福利德是一种天然的植物化学物质,具有强大的抗氧化,抗炎和抗丧性质.
- 这些特性表明,它对包括心脏病在内的各种疾病具有显著的治疗潜力.
研究的目的:
- 为了提供一个全面的概述andrographolide对心血管疾病的影响.
- 检查andrographolide在心血管和血管功能障碍中的重要作用和机制.
- 作为andrographolide在心血管疾病中的作用的参考,并指导未来的治疗开发.
主要方法:
- 文献综述和对andrographolide和心血管疾病现有研究的综合.
- 对andrographolide药理作用的临床前和临床数据的分析.
- 对Andrographolide心脏保护和血管保护作用背后的分子机制的检查.
主要成果:
- 安德罗格拉福利德在心血管病理生理学中表现出显著的保护作用.
- 该化合物的抗氧化,抗炎和抗丧性质是其治疗潜力的关键.
- 证据支持andrographolide在缓解各种血管功能障碍方面的作用.
结论:
- 安德罗格拉福利德作为治疗心血管疾病的新型治疗剂具有相当大的前景.
- 对其机制的进一步研究可以释放其治疗心脏和血管疾病的全部潜力.
- 安德罗格拉福利德代表了开发新策略对抗心血管死亡的有价值的天然化合物.
相关概念视频
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
399
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
399
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:26Heart Failure Drugs: Inotropic Agents
488
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
488
01:16Antianginal Drugs: Nitrates and β-Blockers
486
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
486
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
126
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
126